What can we learn from ‘dropouts’ in clinical trials?

E-ISSN： 1365-2133|178|2|318-319

ISSN： 0007-0963

Source： BRITISH JOURNAL OF DERMATOLOGY, Vol.178, Iss.2, 2018-02, pp. : 318-319

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

B‐type natriuretic peptide and heart failure: what can we learn from clinical trials?

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol. 42, Iss. 9, 2015-09 ,pp. : 881-887

John Wiley & Sons Inc

Access to resources Recommend Favorite

What Can We Learn from Herceptin^® Trials in Metastatic Breast Cancer?

Oncology, Vol. 63, Iss. 1, 2002-11 ,pp. : 39-46

Karger

Access to resources Recommend Favorite

Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 7, 2015-07 ,pp. : 1862-1871

John Wiley & Sons Inc

Access to resources Recommend Favorite

What can we learn from international comparisons of costs by DRG?

By Pirson M. Schenker L. Martins D. Dung Duong Chalé J. Leclercq P.

The European Journal of Health Economics, Vol. 14, Iss. 1, 2013-02 ,pp. : 67-73

Springer Publishing Company

Access to resources Recommend Favorite

Pressure to Lead: What Can We Learn from the Theory?

By Stewart Lisa S P

The British Journal of Occupational Therapy, Vol. 70, Iss. 6, 2007-06 ,pp. : 228-234

College of Occupational Therapists

Access to resources Recommend Favorite